Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia

Blood Cancer Journal

Volumn 3, Issue 11, 2013, Pages

  Hasegawa, D ^a,b   Bugarin, C ^a   Giordan, M ^c   Bresolin, S ^c   Longoni, D ^a   Micalizzi, C ^d   Ramenghi, U ^e   Bertaina, A ^f   Basso, G ^c   Locatelli, F ^f   Biondi, A ^a   Kronnie, G T ^c   Gaipa, G ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c UNIVERSITY OF PADOVA   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

GM CSF; Juvenile myelomonocytic leukemia; Phospho specific flow cytometry; Phospho STAT5

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; K RAS PROTEIN; NEUROFIBROMIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT5 PROTEIN;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; MUTATION; ONCOGENE N RAS; PHENOTYPE; PREDICTIVE VALUE; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; VALIDITY;

EID: 84888407334     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.56     Document Type: Article

References (30)

1. Baumann I, Bennett JM, Niemeyer CM, Thiele J, Shannon K. Juvenile meylomonocytic leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC press: Lyon, France, 2008 82-84.
2. Aricò M, Biondi A, Pui C-H. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488. (Pubitemid 27299088)
3. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukaemia hematopoietic progenitors. Blood 1991; 77: 925-929.
4. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 1994; 83: 2248-2254. (Pubitemid 24112737)
5. Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999; 13: 32-37. (Pubitemid 29043714)
6. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl JMed 1994; 330: 597-601. (Pubitemid 24065793)
7. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148-150. (Pubitemid 36666923)
8. Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009; 114: 1859-1863.
9. Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N et al. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Blood 2010; 115: 1969-1975.
10. Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res 2009; 33: 355-362.
11. Pinkel D. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998; 91: 365-367. (Pubitemid 28018771)
12. Lorenzana A, Lyons H, Sawaf H, Higgins M, Carrigan D, Emanuel PD. Human herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediatr Hematol Oncol 2002; 24: 136-141. (Pubitemid 34150555)
13. Moritake H, Ikeda T, Manabe A, Kamimura S, Nunoi H. Cytomegalovirus infection mimicking juvenile myelomonocytic leukemia showing hypersensitivity to granulocyte- macrophage colony stimulating factor. Pediatr Blood Cancer 2009; 53: 1324-1326.
14. Irish JM, Kotecha N, Nolan GP. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 2006; 6: 146-155. (Pubitemid 43361547)
15. Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 2008; 14: 335-343.
16. Gaipa G, Bugarin C, Longoni D, Cesana S, Molteni C, Faini A et al. Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement. Leukemia 2009; 23: 791-793.
17. Suda T, Miura Y, Mizoguchi H, Ijima H, Eguchi M, Kaku H et al. Characterization of hemopoietic precursor cells in juvenile-type chronic myelocytic leukemia. Leuk Res 1982; 6: 43-53. (Pubitemid 12148711)
18. Estrov Z, Grunberger T, Chan HSL, Freedman MH. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood 1986; 67: 1382-1387. (Pubitemid 16080609)
19. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44: 763-770.
20. Coffer PJ, Koenderman L, de Groot RP. The role of STATs in myeloid differentiation and leukemia. Oncogene 2000; 19: 2511-2522. (Pubitemid 30339207)
21. Platanias LC. Map kinase signaling pathways and hematologic malignancies. Blood 2003; 101: 4667-4679. (Pubitemid 36857719)
22. Kirby MA, Weitzman S, Freedman MH. Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol Oncol 1990; 12: 292-296. (Pubitemid 20323426)
23. Toyoda H, Ido M, Hori H, Hiraiwa H, Hirayama M, Kobayashi M et al. A case of juvenile myelomonocytic leukemia with concomitant cytomegalovirus infection. J Pediatr Hematol Oncol 2004; 26: 606-608. (Pubitemid 39223673)
24. Puri K, Singh P, Das RR, Seth R, Gupta R. Diagnostic dilemma of JMML coexisting with CMV infection. Indian J Pediatr 2011; 78: 485-487.
25. Nishio N, Takahashi Y, Tanaka M, Xu Y, Yoshida N, Sakaguchi H et al. Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia. Leuk Res 2011; 35: 1261-1264.
26. Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N et al. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 1996; 88: 2655-2664. (Pubitemid 26327518)
27. Freedman MH, Hitzler JK, Bunin N, Grunberger T, Squire J. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties. Stem Cells 1996; 14: 690-701. (Pubitemid 26404620)
28. Sawai N, Koike K, Higuchi T, Ogami K, Oda M. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia. Blood 1998; 91: 4065-4073. (Pubitemid 28261967)
29. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118: 217-228. (Pubitemid 38962577)
30. Yoshimi A, Bader P, Matthes-Martin S, Starý J, Sedlacek P, Duffner U et al. European Working Group of MDS in Childhood (EWOG-MDS). Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971-977.